EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions

Tatsuro Takei, Takahiro Tokuda, Naoki Yoshioka, Kenji Ogata, Akiko Tanaka, Shunsuke Kojima, Kohei Yamaguchi, Takashi Yanagiuchi, Tatsuya Nakama, LEADers PAD Investigators

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.03.057 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Tatsuro Takei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan. Electronic address: bamboowell.takei@gmail.com. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Popliteal Artery, Femoral Artery, Peripheral Arterial Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The effects of statins on drug-eluting and drug-coated stents for femoropopliteal lesions are not well known. Therefore, this multicenter retrospective study evaluated the impact of statins on the patency of drug-eluting and drug-coated stents. METHODS: Between January 2018 and December 2021, a total of 449 patients were treated with drug-eluting and drug-coated stents at eight cardiovascular centers in Japan (LEADers femoropopliteal lesion registry). These lesions were divided into statin-treated and non-statin-treated arms. After propensity-score matching, the effects of statins on drug-eluting and drug-coated stents were evaluated. The primary outcome was the 2-year primary patency in the statin and nonstatin groups. The secondary outcomes included secondary patency, freedom from clinically driven target lesion revascularization, and freedom from all-cause mortality at 2 years. RESULTS: After propensity-score matching, the baseline characteristics did not differ significantly between the 134 patient pairs in the statin and nonstatin groups. The primary patency at 2 years was significantly better in the statin group than in the nonstatin group (87.3% vs 75.8%, P = .043). In terms of secondary outcomes, the statin group tended to have better secondary patency than the nonstatin group (94.4% vs 87.5%, P = .064). There was no significant difference between the groups in freedom from clinically driven target lesion revascularization and freedom from all-cause mortality (90.8% vs 84.7%, P = .15; 75.8% vs 70.7%, P = .31, respectively). CONCLUSIONS: The results of this study demonstrated that the statin group had superior primary patency to that of the nonstatin group at 2 years. These findings suggest that statins improve the patency of implanted drug-eluting or drug-coated stents for femoropopliteal lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsPopliteal ArteryFemoral ArteryPeripheral Arterial DiseaseDrug-Eluting StentsEndovascular ProceduresHumansFemaleMaleRetrospective StudiesVascular PatencyAgedTime FactorsJapanRegistriesMiddle AgedProsthesis DesignRisk FactorsTreatment OutcomeAged, 80 and overRisk Assessment

Stichwörter der Autor:innen

Drug-coated stentDrug-eluting stentEndovascular therapyPatencyStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan. Electronic address: bamboowell.takei@gmail.com.
  • Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
  • Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.
  • Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
  • Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.

Zitieren

APA

Takei, T., Tokuda, T., Yoshioka, N., Ogata, K., Tanaka, A., Kojima, S., Yamaguchi, K., Yanagiuchi, T., Nakama, T., & LEADers PAD Investigators (2025). Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.03.057

Vancouver

Takei T, Tokuda T, Yoshioka N, Ogata K, Tanaka A, Kojima S, et al. Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.03.057

BibTeX
@article{Takei2025,
  author = {Takei, Tatsuro and Tokuda, Takahiro and Yoshioka, Naoki and Ogata, Kenji and Tanaka, Akiko and Kojima, Shunsuke and Yamaguchi, Kohei and Yanagiuchi, Takashi and Nakama, Tatsuya and LEADers PAD Investigators, LEADers PAD Investigators},
  title = {Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.03.057}
}
Kostenlos starten →